SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Efficacy and Safety Data From Phase 2B Trials of Janssen's Simeprevir in Hepatitis C Patients With Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for Study of Liver Diseases